These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 38828414
1. Relationship of postprandial fibroblast growth factor 21 with lipids, inflammation and metabolic dysfunction-associated fatty liver disease during oral fat tolerance test. Li X, Zheng K, Liu L, Zhang T, Gu W, Hou X, Geng J, Song G. Front Endocrinol (Lausanne); 2024; 15():1343853. PubMed ID: 38828414 [Abstract] [Full Text] [Related]
5. Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease. Wu T, Ye J, Shao C, Li F, Lin Y, Ma Q, Wang W, Feng S, Zhong B. Front Endocrinol (Lausanne); 2021; 12():691556. PubMed ID: 34899591 [Abstract] [Full Text] [Related]
7. Meals with Similar Fat Content from Different Dairy Products Induce Different Postprandial Triglyceride Responses in Healthy Adults: A Randomized Controlled Cross-Over Trial. Hansson P, Holven KB, Øyri LKL, Brekke HK, Biong AS, Gjevestad GO, Raza GS, Herzig KH, Thoresen M, Ulven SM. J Nutr; 2019 Mar 01; 149(3):422-431. PubMed ID: 30759235 [Abstract] [Full Text] [Related]
8. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia. Jackson KG, Walden CM, Murray P, Smith AM, Minihane AM, Lovegrove JA, Williams CM. Metabolism; 2013 Aug 01; 62(8):1065-9. PubMed ID: 23598085 [Abstract] [Full Text] [Related]
10. Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus. Lei X, Chen H, Xu Y, Yang Z, Zhang L, Wang C, Du H. BMJ Open Diabetes Res Care; 2024 Sep 25; 12(5):. PubMed ID: 39322582 [Abstract] [Full Text] [Related]
11. Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations. Gignac T, Trépanier G, Pradeau M, Morissette A, Agrinier AL, Larose É, Marois J, Pilon G, Gagnon C, Vohl MC, Marette A, Carreau AM. Am J Physiol Endocrinol Metab; 2024 May 01; 326(5):E616-E625. PubMed ID: 38477665 [Abstract] [Full Text] [Related]
15. Postprandial lipaemia in menopausal women with metabolic syndrome. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Hoursalas IS, Manolis A, Cokkinos DV. Maturitas; 2006 Aug 20; 55(1):19-26. PubMed ID: 16443339 [Abstract] [Full Text] [Related]
16. New oral fat tolerance tests feature tailoring of the polyunsaturated/saturated fatty acid ratio to elicit a specific postprandial response. Dekker MJ, Wright AJ, Mazurak VC, Graham TE, Marangoni AG, Robinson LE. Appl Physiol Nutr Metab; 2007 Dec 20; 32(6):1073-81. PubMed ID: 18059580 [Abstract] [Full Text] [Related]
17. Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests. Dekker MJ, Wright AJ, Mazurak VC, Marangoni AG, Rush JW, Graham TE, Robinson LE. J Nutr Biochem; 2009 Sep 20; 20(9):694-704. PubMed ID: 18829281 [Abstract] [Full Text] [Related]